Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDSB | AZN | AMGN | GILD | VRTX |
| Company | Pds Biotechnology Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8500 | 192.98 | 374.28 | 132.62 | 530.00 |
| High | 0.8550 | 193.79 | 375.25 | 136.60 | 533.67 |
| Low | 0.8002 | 191.60 | 366.36 | 132.00 | 512.77 |
| Latest | 0.8351 | 193.12 | 368.10 | 136.36 | 522.25 |
| Change | -0.0110 | +2.96 | +1.66 | +6.75 | -7.34 |
| % Change | -1.30% | +1.56% | +0.45% | +5.21% | -1.39% |
| Volume | 184,900 | 2,130,000 | 1,983,600 | 9,177,200 | 2,292,900 |
| 20-Day Average Volume | 563,195 | 2,010,510 | 3,163,800 | 9,036,980 | 1,933,770 |
| Previous Close | 0.8461 | 190.16 | 366.44 | 129.61 | 529.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9401 | 183.56 | 353.10 | 126.50 | 474.24 |
| 20-Day Raw Stochastic | 9.98% | 85.54% | 82.65% | 98.42% | 88.57% |
| 20-Day Relative Strength | 41.85 | 56.30 | 60.97 | 59.44 | 71.53 |
| Weighted Alpha | -52.45 | +29.49 | +25.01 | +21.19 | +21.99 |
| Today's Opinion | 8% Sell | 24% Buy | 72% Buy | 16% Sell | 72% Buy |
| Previous Opinion | 24% Sell | 8% Buy | 72% Buy | 56% Sell | 72% Buy |
| Last Month's Opinion | 80% Buy | 24% Sell | 16% Buy | 24% Sell | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.12% since 06/29/26 | +1.14% since 06/29/26 | +2.09% since 06/29/26 | +7.94% since 06/29/26 | +4.52% since 06/29/26 |
| Low | 0.8002 on 07/07/26 | 183.49 on 07/01/26 | 356.87 on 06/30/26 | 124.19 on 06/30/26 | 489.62 on 06/30/26 |
| High | 0.9134 on 06/30/26 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 136.60 on 07/07/26 | 533.67 on 07/07/26 |
| 1-Month | |||||
| %Chg | -18.13% since 06/05/26 | +3.86% since 06/05/26 | +5.30% since 06/05/26 | +5.57% since 06/05/26 | +16.88% since 06/05/26 |
| Low | 0.8002 on 07/07/26 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 121.39 on 06/10/26 | 433.80 on 06/10/26 |
| High | 1.1500 on 06/10/26 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 136.60 on 07/07/26 | 533.67 on 07/07/26 |
| 3-Month | |||||
| %Chg | -9.03% since 04/07/26 | -3.83% since 04/07/26 | +8.26% since 04/07/26 | -1.76% since 04/07/26 | +20.93% since 04/07/26 |
| Low | 0.8002 on 07/07/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 1.5500 on 05/14/26 | 207.30 on 04/10/26 | 375.25 on 07/07/26 | 142.97 on 04/09/26 | 533.67 on 07/07/26 |
| 6-Month | |||||
| %Chg | -12.37% since 01/07/26 | +1.47% since 01/07/26 | +7.74% since 01/07/26 | +9.66% since 01/07/26 | +7.87% since 01/07/26 |
| Low | 0.5068 on 03/31/26 | 173.65 on 06/18/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 412.27 on 05/05/26 |
| High | 1.5500 on 05/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 533.67 on 07/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 47,226 | 294,920,672 | 197,770,592 | 160,919,872 | 134,412,608 |
| Shares Outstanding, K | 55,816 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -34,500,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -7,350,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.59 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 05/13/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/12/26 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.07 | 16.93 | 15.68 | 31.39 |